Sabra Healthcare REIT, Inc. (SBRA) Stake Raised by Ameriprise Financial Inc.

Ameriprise Financial Inc. increased its holdings in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 115.1% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,326,601 shares of the real estate investment trust’s stock after purchasing an additional 709,983 shares during the period. Ameriprise Financial Inc. owned approximately 0.74% of Sabra Healthcare REIT worth $29,105,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in SBRA. Zurcher Kantonalbank Zurich Cantonalbank increased its position in Sabra Healthcare REIT by 9.3% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 4,151 shares of the real estate investment trust’s stock worth $100,000 after purchasing an additional 352 shares during the last quarter. Daiwa Securities Group Inc. increased its position in Sabra Healthcare REIT by 15.7% in the second quarter. Daiwa Securities Group Inc. now owns 5,900 shares of the real estate investment trust’s stock worth $142,000 after purchasing an additional 800 shares during the last quarter. Riverhead Capital Management LLC increased its position in Sabra Healthcare REIT by 96.0% in the second quarter. Riverhead Capital Management LLC now owns 6,861 shares of the real estate investment trust’s stock worth $165,000 after purchasing an additional 3,361 shares during the last quarter. Flinton Capital Management LLC increased its position in Sabra Healthcare REIT by 96.1% in the second quarter. Flinton Capital Management LLC now owns 6,868 shares of the real estate investment trust’s stock worth $165,000 after purchasing an additional 3,366 shares during the last quarter. Finally, Laurion Capital Management LP bought a new stake in Sabra Healthcare REIT in the second quarter worth $200,000. Institutional investors own 85.51% of the company’s stock.

Sabra Healthcare REIT, Inc. (SBRA) opened at $19.00 on Wednesday. The company has a debt-to-equity ratio of 0.89, a quick ratio of 1.66 and a current ratio of 1.66. Sabra Healthcare REIT, Inc. has a 1 year low of $18.48 and a 1 year high of $29.10. The firm has a market cap of $3,440.00, a price-to-earnings ratio of 8.50, a price-to-earnings-growth ratio of 2.52 and a beta of 0.92.

The company also recently disclosed a quarterly dividend, which was paid on Thursday, November 30th. Shareholders of record on Wednesday, November 15th were given a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a yield of 1.47%. The ex-dividend date of this dividend was Tuesday, November 14th. Sabra Healthcare REIT’s dividend payout ratio (DPR) is 266.67%.

In other Sabra Healthcare REIT news, Director Milton J. Walters sold 4,615 shares of the business’s stock in a transaction on Thursday, November 30th. The shares were sold at an average price of $19.18, for a total transaction of $88,515.70. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Insiders own 2.60% of the company’s stock.

Several equities research analysts recently weighed in on the stock. Zacks Investment Research cut shares of Sabra Healthcare REIT from a “buy” rating to a “hold” rating in a research report on Wednesday, August 30th. Mizuho upgraded shares of Sabra Healthcare REIT from an “underperform” rating to a “neutral” rating and boosted their price target for the stock from $23.00 to $24.00 in a research report on Monday, September 11th. Jefferies Group upgraded shares of Sabra Healthcare REIT from a “hold” rating to a “buy” rating and set a $25.00 price target on the stock in a research report on Tuesday, August 15th. ValuEngine cut shares of Sabra Healthcare REIT from a “buy” rating to a “hold” rating in a research report on Friday, September 1st. Finally, Bank of America boosted their price target on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock an “underperform” rating in a research report on Friday, September 8th. Two investment analysts have rated the stock with a sell rating, five have given a hold rating and five have issued a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus price target of $24.40.

COPYRIGHT VIOLATION NOTICE: This piece was posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are reading this piece on another website, it was stolen and republished in violation of United States & international copyright legislation. The legal version of this piece can be accessed at https://ledgergazette.com/2017/12/06/sabra-healthcare-reit-inc-sbra-stake-raised-by-ameriprise-financial-inc.html.

Sabra Healthcare REIT Profile

Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.

Want to see what other hedge funds are holding SBRA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sabra Healthcare REIT, Inc. (NASDAQ:SBRA).

Institutional Ownership by Quarter for Sabra Healthcare REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Healthcare REIT Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply